ProfileGDS5678 / 1444142_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 10% 9% 8% 27% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.2684710
GSM967853U87-EV human glioblastoma xenograft - Control 22.205629
GSM967854U87-EV human glioblastoma xenograft - Control 32.204118
GSM967855U87-EV human glioblastoma xenograft - Control 42.5766627
GSM967856U87-EV human glioblastoma xenograft - Control 52.151318
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.244218
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.21558
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.179198
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.169758
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.191068
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.187618
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.173288
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.195168
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.19518